Antifungal Activity Directed Toward the Cell Wall by 2-Cyclohexylidenhydrazo- 4-Phenyl-Thiazole Against Candida albicans

Infectious Disorders Drug Targets
Nívea Pereira de SáSusana Johann

Abstract

The increasing incidence of invasive forms of candidiasis and resistance to antifungal therapy leads us to seek new and more effective antifungal compounds. To investigate the antifungal activity and toxicity as well as to evaluate the potential targets of 2- cyclohexylidenhydrazo-4-phenyl-thiazole (CPT) in Candida albicans. The antifungal activity of CPT against the survival of C. albicans was investigated in Caenorhabditis elegans. Additionally, we determined the effect of CPT on the inhibition of C. albicans adhesion capacity to buccal epithelial cells (BECs), the toxicity of CPT in mammalian cells, and the potential targets of CPT in C. albicans. CPT exhibited a minimum inhibitory concentration (MIC) value of 0.4-1.9 µg/mL. Furthermore, CPT at high concentrations (>60 x MIC) showed no or low toxicity in HepG2 cells and <1% haemolysis in human erythrocytes. In addition, CPT decreased the adhesion capacity of yeasts to the BECs and prolonged the survival of C. elegans infected with C. albicans. Analysis of CPT-treated cells showed that their cell wall was thinner than that of untreated cells, especially the glucan layer. We found that there was a significantly lower quantity of 1,3-β-D-glucan present in CPT-treated cells than...Continue Reading

References

Jul 1, 1978·Infection and Immunity·L H Kimura, N N Pearsall
Jan 1, 1991·Methods in Enzymology·J R Pringle
May 1, 1980·The Journal of Cell Biology·J MolanoE Cabib
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·C M DouglasM el-Sherbeini
Jan 1, 1993·Clinical Microbiology Reviews·R F Hector
Apr 1, 1997·Applied and Environmental Microbiology·T MuraiA Tanaka
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M B EdmondR P Wenzel
Aug 8, 2002·FEMS Microbiology Reviews·Frans M KlisStanley Brul
Aug 14, 2002·Cellular Microbiology·Paula Sundstrom
Apr 2, 2003·European Journal of Medicinal Chemistry·B Shivarama HollaN Suchetha Kumari
Jun 26, 2003·Trends in Microbiology·Frank C OddsNeil A R Gow
Feb 25, 2006·Yeast·Frans M KlisPiet W J De Groot
Jun 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·Guillaume Lesage, Howard Bussey
Oct 21, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Juliana P Lyon, Maria Aparecida de Resende
Feb 6, 2007·PLoS Pathogens·Julia BregerEleftherios Mylonakis
Jun 22, 2007·Molecular Microbiology·Juan Carlos G CortésJuan Carlos Ribas
Sep 9, 2008·Mayo Clinic Proceedings·Anat Gafter-GviliMical Paul
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Jan 22, 2010·Critical Reviews in Microbiology·Michael A Pfaller, Daniel J Diekema
Aug 19, 2010·European Journal of Medicinal Chemistry·A M VijeshShridhar Malladi
May 15, 2012·Eukaryotic Cell·Michael E Johnson, Thomas D Edlind
Feb 20, 2013·Advances in Genetics·Stephen J Free
Mar 26, 2013·PloS One·Marcio NucciUNKNOWN Latin American Invasive Mycosis Network
Sep 3, 2013·Current Opinion in Pharmacology·Marios ArvanitisEleftherios Mylonakis
Feb 22, 2014·Human Molecular Genetics·Bumsup KwonHenry W Querfurth
Mar 17, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jeff S PiotrowskiYoshikazu Ohya
Aug 16, 2015·European Journal of Medicinal Chemistry·Nívea Pereira de SáSusana Johann

❮ Previous
Next ❯

Citations

Jan 29, 2022·Molecular Diversity·Gabriel Corrêa VeríssimoVinícius Gonçalves Maltarollo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.